TOMI Environmental Solutions, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that TOMI Environmental Solutions, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.64M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $7.74M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $7.35M | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | $8.34M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $7.75M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $25.03M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $6.35M | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | $5.58M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $4.99M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $6.34M | Mar 29, 2018 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $4.99M | Mar 29, 2018 |
| FY2017 | Dec 31, 2016 | $6.34M | Mar 29, 2018 |
| FY2016 | Dec 31, 2015 | $4.19M | Mar 29, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.08M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $3.56M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $4.29M | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | $5.06M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $4.59M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $15.04M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $3.91M | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | $3.12M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $3.07M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $3.73M | Mar 29, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.75M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($4.48M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($3.40M) | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | ($2.88M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($4.44M) | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $4.39M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | ($2.30M) | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | ($3.23M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($3.64M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($3.16M) | Mar 29, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.85M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($4.10M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($3.35M) | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | ($2.88M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($4.92M) | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $4.51M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | ($2.08M) | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | ($3.07M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($3.44M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($3.37M) | Mar 29, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $289.9K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $290.7K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $491.8K | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | $352.2K | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $572.7K | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $455.0K | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $340.6K | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | $916.0K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $454.1K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $184.3K | Mar 29, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.20M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($1.44M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($3.60M) | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | ($1.23M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($3.82M) | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $4.58M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | ($814.5K) | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | ($1.77M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($2.43M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($4.50M) | Mar 29, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.2K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $107.9K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $98.1K | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | $200.9K | Apr 1, 2024 |
| FY2020 | Dec 31, 2020 | $289.3K | Mar 30, 2021 |
| FY2020 | Dec 31, 2019 | $145.6K | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | $628.1K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $14.8K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $474.9K | Mar 29, 2018 |
| FY2016 | Dec 31, 2015 | $80.5K | Mar 29, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.03M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $9.69M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $13.36M | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | $15.50M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $16.27M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $16.77M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $8.23M | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | $10.08M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $12.44M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $9.30M | Mar 29, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.45M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $5.59M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $5.00M | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | $4.05M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $2.68M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $3.57M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $7.34M | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | $7.08M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $7.05M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.05M | Mar 29, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $588.5K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $4.10M | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | $8.36M | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | $11.45M | Apr 14, 2025 |
| FY2023 | Dec 31, 2021 | $13.60M | Apr 1, 2024 |
| FY2022 | Dec 31, 2020 | $13.20M | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | $889.5K | Mar 29, 2022 |
| FY2020 | Dec 31, 2018 | $3.00M | Mar 30, 2021 |
| FY2019 | Dec 31, 2017 | $5.39M | Mar 30, 2020 |
| FY2018 | Dec 31, 2016 | $8.25M | Apr 1, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($58.05M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($54.30M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($49.83M) | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | ($46.42M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($43.54M) | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | ($39.11M) | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | ($43.50M) | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | ($41.20M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($37.97M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($34.33M) | Mar 29, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2024 | $88.0K | Mar 31, 2026 |
| FY2021 | Dec 31, 2021 | $5.32M | Mar 29, 2022 |
| FY2021 | Dec 31, 2020 | $5.20M | Mar 29, 2022 |
| FY2021 | Dec 31, 2019 | $897.2K | Mar 29, 2022 |
| FY2020 | Dec 31, 2018 | $2.00M | Mar 30, 2021 |
| FY2019 | Dec 31, 2017 | $4.55M | Mar 30, 2020 |
| FY2018 | Dec 31, 2016 | $948.3K | Apr 1, 2019 |
| FY2017 | Dec 31, 2015 | $5.92M | Mar 29, 2018 |
| FY2016 | Dec 31, 2014 | $160.6K | Mar 29, 2017 |
| FY2015 | Dec 31, 2013 | $706.4K | Mar 30, 2016 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.14M | Mar 31, 2026 |
| FY2019 | Dec 31, 2019 | $5.00M | Mar 30, 2020 |
| FY2019 | Dec 31, 2018 | $4.98M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $5.94M | Apr 1, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 30, 2021 |
| FY2015 | Dec 31, 2015 | 0 | Mar 30, 2016 |
| FY2015 | Dec 31, 2014 | 0 | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | 0 | Mar 24, 2015 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 30, 2021 |
| FY2015 | Dec 31, 2015 | 0 | Mar 30, 2016 |
| FY2015 | Dec 31, 2014 | 0 | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | 0 | Mar 24, 2015 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 20.28M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 20.02M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 19.92M | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | 19.76M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 19.68M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | 16.76M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | 15.59M | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | 124.29M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | 122.05M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 120.83M | Mar 29, 2018 |